Skip to main navigation Skip to search Skip to main content

Erlotinib (OSI-774, Tarceva™), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer

  • Mary Hightower
  • , Chandra P. Belani
  • , Vinay K. Jain

Research output: Contribution to journal › Article › peer-review

14   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Erlotinib (OSI-774, Tarceva™), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.
Sort by